Cargando…

Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial

BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Adalat, Maryam, Khalili, Mohammad, Ayromlou, Hormoz, Haririan, Sajjad, Fazljou, Seyyed Mohammad Bagher, Rezaeizadeh, Hossein, Safari, Ali Akbar, Zargaran, Arman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Salvia Medical Sciences Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343653/
https://www.ncbi.nlm.nih.gov/pubmed/34466472
http://dx.doi.org/10.31661/gmj.v8i0.1212
_version_ 1783734327572430848
author Adalat, Maryam
Khalili, Mohammad
Ayromlou, Hormoz
Haririan, Sajjad
Fazljou, Seyyed Mohammad Bagher
Rezaeizadeh, Hossein
Safari, Ali Akbar
Zargaran, Arman
author_facet Adalat, Maryam
Khalili, Mohammad
Ayromlou, Hormoz
Haririan, Sajjad
Fazljou, Seyyed Mohammad Bagher
Rezaeizadeh, Hossein
Safari, Ali Akbar
Zargaran, Arman
author_sort Adalat, Maryam
collection PubMed
description BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that contains Crocus sativus, Hypericum perforatum, Cinnamon verum, and Vitis vinifera on fatigue and sleep disorders in MS patients. MATERIALS AND METHODS: A Persian medicine remedy containing C.sativus, H.perforatum, C.verum, and V.vinifera was tested for its ability to improve the symptoms of depression in MS patients. This randomized double-blind clinical study was performed among 52 patients with MS who were allocated to their respective research groups through blocked randomization. The patients were treated for 4 weeks with either the drug or the placebo. To quantify the symptoms of depression, Beck depression inventory (BDI) was used. RESULTS: Forty-six patients completed the study. In the course of the study, as the primary outcome, BDI decreased in the drug group (p =0.000) and the placebo group (p =0.001) significantly, but the rate of change in the drug group was significantly higher than in the placebo group (-13.9 ± 8.6 vs. -3.9 ± 4.3, p =0.000). While analyzing time and treatment effect for BDI, significant decreases in BDI were observed for the drug group, but not in the placebo group (p = 0.001). CONCLUSION: The present study suggests that Persian medicine remedy treatment in combination with chemical drugs may improve depression symptoms in MS patients. More investigations are needed to discover the exact mechanisms and processes involved.
format Online
Article
Text
id pubmed-8343653
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Salvia Medical Sciences Ltd
record_format MEDLINE/PubMed
spelling pubmed-83436532021-08-30 Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial Adalat, Maryam Khalili, Mohammad Ayromlou, Hormoz Haririan, Sajjad Fazljou, Seyyed Mohammad Bagher Rezaeizadeh, Hossein Safari, Ali Akbar Zargaran, Arman Galen Med J Original Article BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that contains Crocus sativus, Hypericum perforatum, Cinnamon verum, and Vitis vinifera on fatigue and sleep disorders in MS patients. MATERIALS AND METHODS: A Persian medicine remedy containing C.sativus, H.perforatum, C.verum, and V.vinifera was tested for its ability to improve the symptoms of depression in MS patients. This randomized double-blind clinical study was performed among 52 patients with MS who were allocated to their respective research groups through blocked randomization. The patients were treated for 4 weeks with either the drug or the placebo. To quantify the symptoms of depression, Beck depression inventory (BDI) was used. RESULTS: Forty-six patients completed the study. In the course of the study, as the primary outcome, BDI decreased in the drug group (p =0.000) and the placebo group (p =0.001) significantly, but the rate of change in the drug group was significantly higher than in the placebo group (-13.9 ± 8.6 vs. -3.9 ± 4.3, p =0.000). While analyzing time and treatment effect for BDI, significant decreases in BDI were observed for the drug group, but not in the placebo group (p = 0.001). CONCLUSION: The present study suggests that Persian medicine remedy treatment in combination with chemical drugs may improve depression symptoms in MS patients. More investigations are needed to discover the exact mechanisms and processes involved. Salvia Medical Sciences Ltd 2019-01-01 /pmc/articles/PMC8343653/ /pubmed/34466472 http://dx.doi.org/10.31661/gmj.v8i0.1212 Text en Copyright© 2019, Galen Medical Journal. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) )
spellingShingle Original Article
Adalat, Maryam
Khalili, Mohammad
Ayromlou, Hormoz
Haririan, Sajjad
Fazljou, Seyyed Mohammad Bagher
Rezaeizadeh, Hossein
Safari, Ali Akbar
Zargaran, Arman
Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title_full Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title_fullStr Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title_full_unstemmed Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title_short Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
title_sort antidepressant effects of a persian medicine remedy on multiple sclerosis patients: a double-blinded randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343653/
https://www.ncbi.nlm.nih.gov/pubmed/34466472
http://dx.doi.org/10.31661/gmj.v8i0.1212
work_keys_str_mv AT adalatmaryam antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT khalilimohammad antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT ayromlouhormoz antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT haririansajjad antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT fazljouseyyedmohammadbagher antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT rezaeizadehhossein antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT safarialiakbar antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial
AT zargaranarman antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial